About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT04748029

Evaluation of the Prognostic Role of the Systemic Immune Inflammation Index in Postmenopausal Osteoporosis

This study is a retrospective case-control study. In the study, the data of 304 patients who were evaluated in our clinic between January 2017 and January 2020 with a pre-diagnosis or diagnosis of pos...

Lead sponsor: Ufuk University•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Ufuk University

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Having applied to our clinic with the diagnosis or pre-diagnosis of postmenopausal osteoporosis or osteoporosis with pathological fractures

Exclusion Criteria

•Having a diagnosis of osteoporosis due to conditions other than postmenopausal osteoporosis
•Those with acute or chronic infection, malignancy and systemic diseases that may change the hematological inflammation parameters to be checked
•Persons who are missing one or more of the parameters planned to be considered among the obtained data

Related studies

The Osteoporotic Fracture Classification-based Scoring System for Treatment Decision in Thoracolumbar Osteoporotic Fractures

NCT07027306 · Osteoporotic Fractures, Osteoporosis

RECRUITINGPhase 4

Combined Anabolic Therapy

NCT06558188 · Osteoporosis, Postmenopausal, Osteoporosis

RESTORE: REducing Future fractureS and Improving ouTcOmes of fRagility fracturE

NCT06455085 · Osteoporosis, Osteoporotic Fractures, and more

Single or Repeat Zoledronate Versus Alendronate Following Denosumab (EUROpean Denosumab Effects Consolidation Study)

NCT05575167 · Osteoporosis, Postmenopausal

Percutaneous Vertebroplasty Vs. Sham for Osteoporotic Vertebral Compression Fractures Focusing on Pain and Economy.

NCT06141187 · Osteoporotic Fractures, Vertebral Fracture

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 10, 2021Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment139

Start dateJan 2021

Last updatedFeb 10, 2021

Condition

Osteoporosis, Postmenopausal Osteoporotic Fractures

Locations shown

Ufuk University

Ankara, Çankaya

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 10, 2021Data synced to Clareo: May 17, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions